Is GSK plc halal to invest in?

As of July 2026, GSK plc GSK.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is GSK plc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes GSK plc using these criteria to determine its compliance status.

Can Muslims buy shares of GSK plc?

Muslim investors may consider investing in GSK plc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is GSK plc classified as HALAL?

Musaffa determines the Shariah status of GSK plc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for GSK plc updated?

The Shariah compliance status of GSK plc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like GSK plc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of GSK plc?

You can check the latest Shariah compliance status of GSK plc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

GSK plc GSK.L

Last Updated: Jul 20, 12:00 AM·LSE

GSK.L Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, GSK plc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

GSK plc. Stock Analysis GSK.L

United Kingdom Health Care Large Cap Report: Q1, 2026

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. The Company’s segments include Commercial Operations and Research and Development. The firm is focused on the science of the immune system and advanced technologies, investing in four core therapeutic areas-respiratory, immunology and inflammation; oncology; human immunodeficiency virus (HIV), and infectious diseases. Its specialty medicines prevent and treat diseases, from asthma, cancer and HIV to autoimmune diseases like lupus. General medicines include inhalers for asthma and chronic obstructive pulmonary disease (COPD) with antibiotics. Its portfolio also includes Efimosfermin, a fibroblast growth factor 21 (FGF21) analog therapeutic in clinical development. The firm also engaged in ozureprubart, a long-acting anti-immunoglobulin E (IgE) monoclonal antibody. The firm also owns HS235, a potential molecule for the treatment of pulmonary hypertension (PH).

Key Statistics of GSK plc (GSK.L)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

GBX1,881.00GBX1,920.00

Today's Open

GBX1,909.85

Volume

4.44M

P/E Ratio (TTM)

13.43

52 Week Range

GBX1,361.00GBX2,282.00

Market Cap

8.02T

Avg. Volume

6.48M

Dividend Yield

3.38%

Financial Metrics & Statements of GSK plc (GSK.L)

Super Investors Invested in GSK plc (GSK.L)

FAQ's for GSK plc (GSK.L)

As of July 2026, GSK plc GSK.L is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes GSK plc using these criteria to determine its compliance status.
Muslim investors may consider investing in GSK plc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of GSK plc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of GSK plc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of GSK plc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.